Clinical Trials Logo

Clinical Trial Summary

this summary studied the predictive values of factor V Leiden mutation , doppler indices , placental pathology to unfavorable fetal and maternal outcomes


Clinical Trial Description

leiden mutation is activated protein C resistance with hypercoagulable states and increased thrombotic risk. 99 % are heterozygous and 1 % is homozygous , very rare cases are psoudohomozygous with factor V deficiency. relation to this mutation was studied in severe preeclamptic patients. doppler indices of uterine arteries , increased pulsetility index or unilateral or bilateral uterine artery notch and placental pathology were studied. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03871764
Study type Observational [Patient Registry]
Source Cairo University
Contact
Status Completed
Phase
Start date December 1, 2015
Completion date April 2017